EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Scope & Guideline
Connecting researchers to the forefront of digestive science.
Introduction
Aims and Scopes
- Clinical Research in Gastroenterology and Hepatology:
The journal publishes studies that investigate clinical outcomes, treatment efficacy, and disease management in gastroenterology and hepatology, emphasizing real-world applications and patient-centered care. - Innovative Diagnostic and Therapeutic Techniques:
Research on the development and evaluation of new diagnostic tools and therapeutic interventions, including endoscopic procedures and minimally invasive techniques, is a core focus area. - Epidemiological Studies and Public Health:
The journal features epidemiological research that explores the prevalence, risk factors, and public health implications of gastrointestinal and liver diseases, contributing to evidence-based healthcare policies. - Basic and Translational Research:
Studies that investigate the underlying mechanisms of gastrointestinal and liver diseases at the molecular and cellular levels, including pathophysiology and genetic factors, are highly valued. - Nutritional and Lifestyle Interventions:
The journal encourages research that examines the impact of diet, nutrition, and lifestyle modifications on gastrointestinal and liver health, reflecting the growing interest in holistic approaches to disease management. - Patient Quality of Life and Health Economics:
Research assessing the quality of life in patients with gastrointestinal and liver diseases, as well as cost-effectiveness analyses of treatments, is increasingly prominent in the journal.
Trending and Emerging
- Artificial Intelligence in Gastroenterology:
There is an increasing trend in the exploration of artificial intelligence and machine learning applications for improving diagnostic accuracy and treatment outcomes in gastroenterology, reflecting the digital transformation in healthcare. - Microbiome Research:
Studies investigating the role of the gut microbiome in gastrointestinal health and disease, including its impact on treatment responses and disease mechanisms, have gained significant attention in recent years. - Personalized Medicine and Targeted Therapies:
The focus on personalized medicine, especially in the context of inflammatory bowel disease and liver disorders, is trending, with research aimed at tailoring treatments based on individual patient profiles. - Integrative Approaches to Treatment:
There is a growing interest in integrative medicine, emphasizing the combination of conventional therapies with dietary, lifestyle, and complementary approaches to enhance patient outcomes. - Longitudinal Cohort Studies:
The trend of conducting long-term cohort studies to track disease progression and treatment efficacy over time is rising, providing valuable insights into chronic conditions such as hepatitis and inflammatory bowel disease.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable shift towards innovative therapies and personalized medicine, leading to a decreased focus on traditional pharmacological treatments and their efficacy in managing gastrointestinal diseases. - Single-Center Studies:
The prevalence of single-center studies has diminished as there is a growing emphasis on multicenter collaborations that provide broader data and enhance the generalizability of findings across diverse populations. - Non-Interventional Studies:
The journal has seen a decline in the publication of purely observational studies that do not contribute to direct clinical applications or advancements in treatment protocols. - Basic Science without Clinical Relevance:
Research that lacks direct applicability to clinical practice or does not address pressing clinical questions has become less favored, as the journal prioritizes studies with tangible impacts on patient care. - Outdated Techniques and Technologies:
As new diagnostic and therapeutic techniques emerge, studies focusing on outdated or less effective methods have decreased, reflecting the journal's commitment to advancing contemporary practices.
Similar Journals
Cellular and Molecular Gastroenterology and Hepatology
Advancing knowledge in gastrointestinal and liver health.Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Illuminating the Complexities of Gastrointestinal DiseasesSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.
DIGESTIVE AND LIVER DISEASE
Advancing knowledge in gastroenterology and hepatology.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
Gastroenterologia y Hepatologia
Fostering innovation in the diagnosis and treatment of liver diseases.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
Gastroenterology
Empowering Healthcare Professionals with Essential InsightsGastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.
Hepatology Forum
Illuminating the path to better liver health.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.
Gastrointestinal Disorders
Empowering Professionals with Cutting-Edge GI ResearchGastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.
HPB
Transforming patient care through cutting-edge research.HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.
Frontline Gastroenterology
Pioneering Research for Liver and Gut HealthFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.
Journal of Gastrointestinal and Liver Diseases
Driving Impactful Discoveries in Digestive HealthThe Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.
With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.